Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma.
BACKGROUND: We investigated cell cycle kinetics of nodular lesions in cirrhosis to differentiate hepatocellular carcinoma (HCC) from its precursor lesions. METHODS: Twelve small HCC, 10 regenerative (RN), six large regenerative (LRN), and five dysplastic nodules (DN), identified in explant cirrhoti...
Autors principals: | Quaglia, A, McStay, M, Stoeber, K, Loddo, M, Caplin, M, Fanshawe, T, Williams, G, Dhillon, A |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2006
|
Ítems similars
-
Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
per: Dudderidge, T, et al.
Publicat: (2005) -
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast.
per: Shetty, A, et al.
Publicat: (2005) -
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
per: He, Michelle J., et al.
Publicat: (2022) -
Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
per: Yelena Lapidot, et al.
Publicat: (2020-06-01) -
Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
per: Michelle Junyi He, et al.
Publicat: (2022-11-01)